KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 74 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,609,162 | -0.1% | 270,941 | -6.7% | 0.00% | – |
| Q2 2023 | $2,612,475 | -0.6% | 290,275 | -13.2% | 0.00% | – |
| Q1 2023 | $2,627,000 | +118715.0% | 334,309 | +2.2% | 0.00% | – |
| Q4 2022 | $2,211 | -99.9% | 327,003 | +140.1% | 0.00% | – |
| Q3 2022 | $1,976,000 | +39.5% | 136,194 | -5.3% | 0.00% | – |
| Q2 2022 | $1,416,000 | +615.2% | 143,851 | +971.6% | 0.00% | – |
| Q1 2022 | $198,000 | +39.4% | 13,424 | +24.9% | 0.00% | – |
| Q4 2021 | $142,000 | -10.7% | 10,747 | +18.2% | 0.00% | – |
| Q3 2021 | $159,000 | -24.3% | 9,091 | +3.8% | 0.00% | – |
| Q2 2021 | $210,000 | -1.9% | 8,759 | +5.1% | 0.00% | – |
| Q1 2021 | $214,000 | -68.3% | 8,334 | -76.6% | 0.00% | – |
| Q4 2020 | $676,000 | +129.9% | 35,573 | +52.8% | 0.00% | – |
| Q3 2020 | $294,000 | -21.8% | 23,280 | -25.2% | 0.00% | – |
| Q2 2020 | $376,000 | -17.2% | 31,128 | -47.6% | 0.00% | – |
| Q1 2020 | $454,000 | +33.1% | 59,365 | +210.1% | 0.00% | – |
| Q4 2019 | $341,000 | +675.0% | 19,142 | +400.2% | 0.00% | – |
| Q3 2019 | $44,000 | -94.5% | 3,827 | -89.7% | 0.00% | – |
| Q2 2019 | $806,000 | -54.6% | 37,308 | -39.9% | 0.00% | – |
| Q1 2019 | $1,776,000 | +144.3% | 62,062 | +68.7% | 0.00% | – |
| Q4 2018 | $727,000 | +486.3% | 36,795 | +555.6% | 0.00% | – |
| Q3 2018 | $124,000 | +110.2% | 5,612 | -22.7% | 0.00% | – |
| Q2 2018 | $59,000 | -70.4% | 7,262 | -65.3% | 0.00% | – |
| Q1 2018 | $199,000 | -29.7% | 20,940 | -28.0% | 0.00% | – |
| Q4 2017 | $283,000 | – | 29,073 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |